Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL563945 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL2288147 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL6695830 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL917843 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL1270542 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| Hydrochloric Acid SCHEMBL8210048 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL6692218 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL1270406 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL10693026 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL922126 | 0.96 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115191-A1 | Nilotinib Compositions with Enhanced Solubility | NEOFORM BIOPHARMACEUTICAL LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-12442728-B2 | Preservative solution for heme protein, and method for stabilizing heme protein | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2025-10-14 | — | — | US | claimed |
| CN-120129539-A | Radionuclide composition and method for detecting tumor cells by using radionuclide composition | 纽约州立大学研究基金会 | 2025-06-10 | — | — | CN | claimed |
| CN-119977129-A | Butanedisulfonic acid waste liquid neutralization treatment device | 山东鲁抗三叶生物制药有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119753047-A | Preparation process of high-purity butanedisulfonic acid ademetionine | 江西诚志生物工程有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119574729-A | Method for detecting antioxidant in adenosylmethionine butanesulfonate for injection | 石家庄四药有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119499265-A | Butanedisulfonic acid adenomethionine for injection and preparation method thereof | 海南倍特药业有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119439655-A | Corrosion-resistant developing solution and preparation method and application thereof | 上海戎洲芯科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119103813-B | Preparation method of high-temperature-resistant butanedisulfonic acid ademetionine for injection | 成都天兴致远生物科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-116408051-B | Sulfonic acid anion hybridization porous material, preparation method and ethylene-ethane separation method | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| WO-1999059571-A1 | USE OF AMYLOID INHIBITORS FOR MODULATING NEURONAL CELL DEATH | NEUROCHEM, INC. (US) | 1999-11-25 | — | — | WO | claimed |
| WO-1999045947-A1 | IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES | UNIVERSITY OF WASHINGTON (US) | 1999-09-16 | — | — | WO | claimed |
| US-5840294-A | INHIBITING AMYLOID DEPOSITION BY ADMINISTERING A THERAPEUTIC COMPOUND COMPRISING AN ANIONIC GROUP AND A CARRIER MOLECULE | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1998-11-24 | — | — | US | claimed |
| US-5776911-A | Use of (S)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia | KNOLL AKTIENGESELLSCAHFT (DE) | 1998-07-07 | — | — | US | claimed |
| EP-0814842-A1 | METHOD FOR TREATING AMYLOIDOSIS | Queen's University at Kingston (CA) | 1998-01-07 | — | — | EP | claimed |
| US-5643562-A | ANTIDEPOSIT AGENTS FOR PROTEINS FOR MEDICAL DIAGNOSIS OF DISEASES | QUEEN'S UNIVERSITY OF KINGSTON (CA) | 1997-07-01 | — | — | US | claimed |
| CN-1134401-A | New-type scale-inhibiting dispersion agent for water treatment | TIANJIN CHEMICAL INST MINISTRY (CN) | 1996-10-30 | — | — | CN | claimed |
| WO-1996028187-A1 | METHOD FOR TREATING AMYLOIDOSIS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1996-09-19 | — | — | WO | claimed |
| EP-0501293-A1 | Use of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis determined by total parenteral nutrition | BIORESEARCH S.p.A. (IT) | 1992-09-02 | — | — | EP | claimed |
| US-4016236-A | WET SPINNING AN ANISOTROPIC DOPE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1977-04-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115191-A1 | Nilotinib Compositions with Enhanced Solubility | TP53, PHF8, SMCHD1 | APP 4625/4885PTGS1 3665/4885PDE4A 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.